{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Eye+Movement&page=10", "query": { "condition": "Eye Movement", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 251, "total_pages": 26, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Eye+Movement&page=11&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Eye+Movement&page=9&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-29T20:12:42.812Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00703677", "title": "A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Progressive Supranuclear Palsy", "Corticobasal Degeneration" ], "interventions": [ { "name": "Lithium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Westat", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 17, "start_date": "2008-09", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2024-05-17", "last_synced_at": "2026-10-29T20:12:42.812Z", "location_count": 8, "location_summary": "Chicago, Illinois • Louisville, Kentucky • Baltimore, Maryland + 4 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00703677" }, { "nct_id": "NCT04652856", "title": "Neurocognitive Basis of Attention and Eye Movement Guidance in the Real World Scenes", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cognition", "Attention", "Eye Movements" ], "interventions": [ { "name": "Electrical Brain Stimulation", "type": "DEVICE" }, { "name": "Sham Electrical Brain Stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Avniel Ghuman", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2022-05", "completion_date": "2022-06", "has_results": false, "last_update_posted_date": "2022-06-13", "last_synced_at": "2026-10-29T20:12:42.812Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04652856" }, { "nct_id": "NCT05888441", "title": "Obstacle Negotiation in Older People With and Without Vision Impairment", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Low Vision" ], "interventions": [ { "name": "Obstacle characteristics", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2023-04-14", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2025-11-13", "last_synced_at": "2026-10-29T20:12:42.812Z", "location_count": 1, "location_summary": "Bloomington, Indiana", "locations": [ { "city": "Bloomington", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05888441" }, { "nct_id": "NCT01616108", "title": "Bupivacaine Injection of Eye Muscles to Treat Strabismus", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Strabismus", "Esotropia", "Exotropia", "Graves Disease", "Ptosis, Eyelid" ], "interventions": [ { "name": "Bupivacaine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Smith-Kettlewell Eye Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "8 Years to 95 Years" }, "enrollment_count": 120, "start_date": "2012-04", "completion_date": "2020-09", "has_results": false, "last_update_posted_date": "2019-09-23", "last_synced_at": "2026-10-29T20:12:42.812Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01616108" }, { "nct_id": "NCT01694940", "title": "North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mitochondrial Disorders", "Mitochondrial Genetic Disorders", "Mitochondrial Diseases", "Disorder of Mitochondrial Respiratory Chain Complexes", "Deletion and Duplication of Mitochondrial DNA" ], "interventions": [], "intervention_types": [], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1000, "start_date": "2011-01-31", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-02-04", "last_synced_at": "2026-10-29T20:12:42.812Z", "location_count": 16, "location_summary": "San Diego, California • Stanford, California • Aurora, Colorado + 12 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Gainsville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01694940" }, { "nct_id": "NCT00653783", "title": "Diagnostic and Prognostic Biomarkers in Parkinson Disease", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson Disease", "Multiple System Atrophy", "Progressive Supranuclear Palsy" ], "interventions": [], "intervention_types": [], "sponsor": "The Parkinson Study Group", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2007-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2008-12-31", "last_synced_at": "2026-10-29T20:12:42.812Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00653783" }, { "nct_id": "NCT01931644", "title": "At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "All Diagnosed Health Conditions", "ADD/ADHD", "Alopecia Areata", "Ankylosing Spondylitis", "Asthma", "Atopic Dermatitis Eczema", "Beta Thalassemia", "Bipolar Disorder", "Breast Cancer", "Celiac Disease", "Cervical Cancer", "Chronic Inflammatory Demyelinating Polyneuropathy", "Chronic Kidney Diseases", "Chronic Obstructive Pulmonary Disease", "Colon Cancer", "Colorectal Cancer", "Crohn's Disease", "Cystic Fibrosis", "Depression", "Diabetes Mellitus", "Duchenne Muscular Dystrophy", "Endometriosis", "Epilepsy", "Facioscapulohumeral Muscular Dystrophy", "G6PD Deficiency", "General Anxiety Disorder", "Hepatitis B", "Hereditary Hemorrhagic Telangiectasia", "HIV/AIDS", "Human Papilloma Virus", "Huntington's Disease", "Idiopathic Thrombocytopenic Purpura", "Insomnia", "Kidney Cancer", "Leukemia", "Lung Cancer", "Lupus Nephritis", "Lymphoma", "Melanoma", "Multiple Myeloma", "Multiple Sclerosis", "Myositis", "Myotonic Dystrophy", "Ovarian Cancer", "Pancreatic Cancer", "Parkinson's Disease", "Polycystic Kidney Diseases", "Prostate Cancer", "Psoriasis", "Psoriatic Arthritis", "Rosacea", "Scleroderma", "Sickle Cell Anemia", "Sickle Cell Trait", "Sjogren's Syndrome", "Skin Cancer", "Spinal Muscular Atrophy", "Systemic Lupus Erythematosus", "Thrombotic Thrombocytopenic Purpura", "Trisomy 21", "Ulcerative Colitis" ], "interventions": [], "intervention_types": [], "sponsor": "Sanguine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 17667, "start_date": "2013-07", "completion_date": "2024-04", "has_results": false, "last_update_posted_date": "2024-04-18", "last_synced_at": "2026-10-29T20:12:42.812Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01931644" }, { "nct_id": "NCT00559234", "title": "Potential Research Participants for Future Studies of Inherited Eye Diseases", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cataract", "Glaucoma", "Retinitis Pigmentosa", "Macular Degeneration", "Strabismus" ], "interventions": [], "intervention_types": [], "sponsor": "National Eye Institute (NEI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 400, "start_date": "2007-11-09", "completion_date": "2008-10-03", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-10-29T20:12:42.812Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00559234" }, { "nct_id": "NCT04195711", "title": "Comparative Validation of \"Blinq\" and \"2WIN\" Vision Screeners", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Strabismic Amblyopia", "Refractive Amblyopia", "Strabismus" ], "interventions": [ { "name": "objective pediatric vision screen, \"blinq,\"", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Alaska Blind Child Discovery", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "1 Year", "maximum_age": "65 Years", "sex": "ALL", "summary": "1 Year to 65 Years" }, "enrollment_count": 100, "start_date": "2019-11-18", "completion_date": "2019-11-26", "has_results": false, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-10-29T20:12:42.812Z", "location_count": 1, "location_summary": "Anchorage, Alaska", "locations": [ { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04195711" }, { "nct_id": "NCT01056965", "title": "Davunetide (AL-108) in Predicted Tauopathies - Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Predicted Tauopathies, Including", "Progressive Supranuclear Palsy", "Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17", "Corticobasal Degeneration Syndrome", "Progressive Nonfluent Aphasia" ], "interventions": [ { "name": "davunetide (AL-108, NAP)", "type": "DRUG" }, { "name": "Placebo nasal spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 12, "start_date": "2010-01", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2019-04-05", "last_synced_at": "2026-10-29T20:12:42.812Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01056965" } ] }